TON - September 2017, Vol 10, No 5

The September issue of The Oncology Nurse-APN/PA (TON) is full of important news and updates for oncology nurses.
Intermountain Cedar City Hospital in Cedar City, UT, one of the top 20 rural hospitals in the United States, offers comprehensive treatment care for patients with cancer.
Patient-reported outcomes (PROs) are increasingly being incorporated into clinical trial design, which has led to advances that benefit patients.
Healthcare practitioners can now tell their patients with stage III colon cancer that eating tree nuts (eg, walnuts, almonds, hazelnuts, cashews, and pecans) and maintaining a healthy lifestyle can improve their chances of overall survival as well as recurrence-free survival.
Historically, therapies for patients with MM included high-dose dexamethasone, alkylating agents, and autologous stem cell transplantation. In the late 1990s, a new era in myeloma treatment began with the introduction of the immunomodulatory drug (IMiD) thalidomide, followed by subsequent development of the proteasome inhibitors bortezomib and carfilzomib, and the next-generation IMiDs lenalidomide and pomalidomide.
A brief, Internet-based psychological intervention improved quality of life, reduced fatigue, and reduced distress levels in patients with newly diagnosed cancer.
Hair loss is a well-known side effect of chemotherapy, but alopecia can also occur with endocrine therapy.
On August 17, 2017, the FDA approved a new indication for olaparib, in tablet form, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer whose disease completely or partially responded to chemotherapy that was platinum-based, regardless of their BRCA mutation status.
We all know that green is good if it is the vibrant color of leafy vegetables. For consumer health, leafy vegetables warrant a constant coaxing from the ranks of nutritionists, television health gurus, and medical practitioners, thanks to numerous studies showcasing the reasons why.
Lynch syndrome is a hereditary cancer syndrome that places individuals at an increased risk for colorectal, endometrial, stomach, ovarian, urothelial, and other cancers.
Page 1 of 2
Results 1 - 10 of 14